Mycobacterium Citations List: May, 2019

Literature Citations

1. Extraction Methods and Computational Approaches for Evaluation of Antimicrobial Compounds from Capparis zeylanica L. Arulmozhi, P., S. Vijayakumar, P.K. Praseetha, and S. Jayanthi. Analytical Biochemistry, 2019. 572: p. 33-44. PMID[30825430].
[PubMed]. TB_05_2019.

2. New Quinolone-based Thiosemicarbazones Showing Activity against Plasmodium falciparum and Mycobacterium tuberculosis. Beteck, R.M., R. Seldon, A. Jordaan, D.F. Warner, H.C. Hoppe, D. Laming, and S.D. Khanye. Molecules, 2019. 24(9): E1740. PMID[31060249]. PMCID[PMC6540015].
[PubMed]. TB_05_2019.

3. The Cyclic Nitroxide Antioxidant 4-Methoxy-TEMPO Decreases Mycobacterial Burden in Vivo through Host and Bacterial Targets. Black, H.D., W. Xu, E. Hortle, S.I. Robertson, W.J. Britton, A. Kaur, E.J. New, P.K. Witting, B. Chami, and S.H. Oehlers. Free Radical Biology and Medicine, 2019. 135: p. 157-166. PMID[30878645].
[PubMed]. TB_05_2019.

4. Discovery of (3-Benzyl-5-hydroxyphenyl)carbamates as New Antitubercular Agents with Potent in Vitro and in Vivo Efficacy. Cheng, Y.J., Z.Y. Liu, H.J. Liang, C.T. Fang, N.N. Zhang, T.Y. Zhang, and M. Yan. Molecules, 2019. 24(10): E2021. PMID[31137832].
[PubMed]. TB_05_2019.

5. Structure-guided Drug Design of 6-Substituted adenosine Analogues as Potent Inhibitors of Mycobacterium tuberculosis Adenosine Kinase. Crespo, R.A., Q. Dang, N.E. Zhou, L.M. Guthrie, T.C. Snavely, W. Dong, K.A. Loesch, T. Suzuki, L. You, W. Wang, T. O'Malley, T. Parish, D.B. Olsen, and J.C. Sacchettini. Journal of Medicinal Chemistry, 2019. 62(9): p. 4483-4499. PMID[31002508]. PMCID[PMC6511943].
[PubMed]. TB_05_2019.

6. Characterization of MenA (Isoprenyl diphosphate:1,4-diHydroxy-2-naphthoate isoprenyltransferase) from Mycobacterium tuberculosis. Dhiman, R.K., V. Pujari, J.M. Kincaid, M.A. Ikeh, T. Parish, and D.C. Crick. Plos One, 2019. 14(4): e0214958. PMID[30978223]. PMCID[PMC6461227].
[PubMed]. TB_05_2019.

7. Comparative Analysis of Volatile Constituents of Pachira aquatica Aubl. And Pachira glabra Pasq., Their Anti-mycobacterial and anti-Helicobacter pylori Activities and Their Metabolic Discrimination Using Chemometrics. Gamal El-Din, M.I., F.S. Youssef, M.L. Ashour, O.A. Eldashan, and A.N.B. Singab. Journal of Essential Oil Bearing Plants, 2018. 21(6): p. 1550-1567. ISI[000466497300011].
[WOS]. TB_05_2019.

8. Structure-based Design, Synthesis, and Biological Evaluation of Non-acyl sulfamate Inhibitors of the Adenylate-forming Enzyme MenE. Evans, C.E., Y. Si, J.S. Matarlo, Y. Yin, J.B. French, P.J. Tonge, and D.S. Tan. Biochemistry, 2019. 58(14): p. 1918-1930. PMID[30912442].
[PubMed]. TB_05_2019.

9. Chemical Disarming of Isoniazid Resistance in Mycobacterium tuberculosis. Flentie, K., G.A. Harrison, H. Tukenmez, J. Livny, J.A.D. Good, S. Sarkar, D.X. Zhu, R.L. Kinsella, L.A. Weiss, S.D. Solomon, M.E. Schene, M.R. Hansen, A.G. Cairns, M. Kulen, T. Wixe, A.E.G. Lindgren, E. Chorell, C. Bengtsson, K.S. Krishnan, S.J. Hultgren, C. Larsson, F. Almqvist, and C.L. Stallings. Proceedings of the National Academy of Sciences of the United States of America, 2019. 116(21): p. 10510-10517. PMID[31061116].
[PubMed]. TB_05_2019.

10. Bactericidal Potency and Extended Serum Life of Stereo-chemically Engineered Peptides against Mycobacterium. Hazam, P.K., A. Singh, N. Chaudhary, and V. Ramakrishnan. International Journal of Peptide Research and Therapeutics, 2019. 25(2): p. 465-472. ISI[000465597100006].
[WOS]. TB_05_2019.

11. Synthesis and Characterization of Polyaniline-drug Conjugates as Effective Antituberculosis Agents. Kashyap, G., G. Ameta, C. Ameta, R. Ameta, and P.B. Punjabi. Bioorganic and Medicinal Chemistry Letters, 2019. 29(11): p. 1363-1369. PMID[30935794].
[PubMed]. TB_05_2019.

12. In Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline against Drug-resistant Clinical Isolates of Mycobacterium abscessus. Kaushik, A., N.C. Ammerman, O. Martins, N.M. Parrish, and E.L. Nuermberger. Antimicrobial Agents and Chemotherapy, 2019. 63(6): e00470-00419. PMID[30962331].
[PubMed]. TB_05_2019.

13. Peptidyl-prolyl isomerase-B Is Involved in Mycobacterium tuberculosis Biofilm Formation and a Generic Target for Drug Repurposing-based Intervention. Kumar, A., A. Alam, S. Grover, S. Pandey, D. Tripathi, M. Kumari, M. Rani, A. Singh, Y. Akhter, N.Z. Ehtesham, and S.E. Hasnain. NPJ Biofilms and Microbiomes, 2019. 5: p. 3. PMID[30675370]. PMCID[PMC6333787].
[PubMed]. TB_05_2019.

14. Targeting HIV-TB Coinfection by Developing Novel Piperidin-4-substituted Imines: Design, Synthesis, in Vitro and in Silico Studies. Kumar, A., R. Revathi, D. Sriram, F. Curreli, A.K. Debnath, K.S. Pai, and S.G. Kini. Archiv der Pharmazie, 2019. 352(6): e1800358. PMID[31066103].
[PubMed]. TB_05_2019.

15. Inhibition of Pseudomonas aeruginosa and Mycobacterium tuberculosis Disulfide Bond Forming Enzymes. Landeta, C., L. McPartland, N.Q. Tran, B.M. Meehan, Y. Zhang, Z. Tanweer, S. Wakabayashi, J. Rock, T. Kim, D. Balasubramanian, R. Audette, M. Toosky, J. Pinkham, E.J. Rubin, S. Lory, G. Pier, D. Boyd, and J. Beckwith. Molecular Microbiology, 2019. 111(4): p. 918-937. PMID[30556355]. PMCID[PMC6458069].
[PubMed]. TB_05_2019.

16. Discovery and Biosynthesis of Atrovimycin, an Antitubercular and Antifungal Cyclodepsipeptide Featuring Vicinal-dihydroxylated cinnamic acyl Chain. Liu, Q., Z. Liu, C. Sun, M. Shao, J. Ma, X. Wei, T. Zhang, W. Li, and J. Ju. Organic Letters, 2019. 21(8): p. 2634-2638. PMID[30958008].
[PubMed]. TB_05_2019.

17. Synthesis and Antitubercular Activity of New N-5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl-(nitroheteroaryl)carboxamide S. Martinez, R., G.J.N. Zamudio, G. Pretelin-Castillo, R.O. Torres-Ochoa, J.L. Medina-Franco, C.I.E. Pinzon, M.S. Miranda, E. Hernandez, and B. Alanis-Garza. Heterocyclic Communications, 2019. 25(1): p. 52-59. ISI[000467397300008].
[WOS]. TB_05_2019.

18. Sulfated Ceria Catalyzed Synthesis of Imidazopyridines and Their Implementation as DNA Minor Groove Binders. Mohan, S., S. Rangappa, N.C. Anilkumar, J.E. Fuchs, A. Bender, Basappa, K.S. Rangappa, and R. Bhatnagar. Chemistry and Biodiversity, 2019. 16(5): e1800435. PMID[30702795].
[PubMed]. TB_05_2019.

19. Gut Microbiota Metabolite Indole propionic acid Targets Tryptophan Biosynthesis in Mycobacterium tuberculosis. Negatu, D.A., Y. Yamada, Y. Xi, M.L. Go, M. Zimmerman, U. Ganapathy, V. Dartois, M. Gengenbacher, and T. Dick. mBio, 2019. 10(2): e02781-02718. PMID[30914514]. PMCID[PMC6437058].
[PubMed]. TB_05_2019.

20. The Evaluation of the Anti-cancer Drug Elesclomol That Forms a Redox-active Copper Chelate as a Potential Anti-tubercular Drug. Ngwane, A.H., R.D. Petersen, B. Baker, I. Wiid, H.N. Wong, and R.K. Haynes. IUBMB Life, 2019. 71(5): p. 532-538. PMID[30698324].
[PubMed]. TB_05_2019.

21. Biochemical Characterization of Acyl-coenzyme a Synthetases Involved in Mycobacterial Steroid Side-chain Catabolism and Molecular Design: Synthesis of an Anti-mycobacterial Agent. Niu, Y., F. Ge, Y. Yang, Y. Ren, W. Li, G. Chen, D. Wen, F. Liu, and L. Xiong. 3 Biotech, 2019. 9(5): p. 169. PMID[30997306]. PMCID[PMC6453995].
[PubMed]. TB_05_2019.

22. Synthesis and Biological Evaluation of 2-Chloro-3-[(thiazol-2-yl)amino]-1,4-naphthoquinones. Olawode, E.O., R. Tandlich, E. Prinsloo, M. Isaacs, H. Hoppe, R. Seldon, D.F. Warner, V. Steenkamp, and P.T. Kaye. Bioorganic and Medicinal Chemistry Letters, 2019. 29(13): p. 1572-1575. PMID[31080006].
[PubMed]. TB_05_2019.

23. A Novel Codrug Made of the Combination of Ethionamide and Its Potentiating Booster: Synthesis, Self-assembly into Nanoparticles and Antimycobacterial Evaluation. Pastor, A., A. Machelart, X. Li, N. Willand, A. Baulard, P. Brodin, R. Gref, and D. Desmaele. Organic and Biomolecular Chemistry, 2019. 17(20): p. 5129-5137. PMID[31073555].
[PubMed]. TB_05_2019.

24. Synergistic Potential of Juniperus communis and Helichrysum italicum Essential Oils against Nontuberculous Mycobacteria. Peruc, D., B. Ticac, M. Abram, D. Broznic, S. Stifter, M.M. Staver, and I. Gobin. Journal of Medical Microbiology, 2019. 68(5): p. 703-710. PMID[30916640].
[PubMed]. TB_05_2019.

25. Preclinical Development of Inhalable D-Cycloserine and Ethionamide to Overcome Pharmacokinetic Interaction and Enhance Efficacy against Mycobacterium tuberculosis. Ranjan, R., A. Srivastava, R. Bharti, T. Roy, S. Verma, L. Ray, and A. Misra. Antimicrobial Agents and Chemotherapy, 2019. 63(6): e00099-00019. PMID[30962335].
[PubMed]. TB_05_2019.

26. A Significant Therapeutic Effect of Silymarin Administered Alone, or in Combination with Chemotherapy, in Experimental Pulmonary Tuberculosis Caused by Drug-sensitive or Drug-resistant Strains: In Vitro and in Vivo Studies. Rodriguez-Flores, E.M., D. Mata-Espinosa, J. Barrios-Payan, B. Marquina-Castillo, M. Castanon-Arreola, and R. Hernandez-Pando. Plos One, 2019. 14(5): e0217457. PMID[31145751].
[PubMed]. TB_05_2019.

27. Design, Synthesis, and Evaluation of the Antimycobacterial Activity of 3-Mercapto-1,2,4-triazole-pyrrole Hybrids. Roman, G., A.C. Bostanaru, V. Nastasa, and M. Mares. Turkish Journal of Chemistry, 2019. 43(2): p. 531-546. ISI[000466785800014].
[WOS]. TB_05_2019.

28. Evaluation of Antimycobacterial Activity from Marine and Freshwater Microalgae. Ruiz-Guereca, D.A., A.F. Licea-Navarro, and M.D. Sanchez-Saavedra. Revista De Biologia Marina y Oceanografia, 2019. 54(1): p. 82-90. ISI[000467569200009].
[WOS]. TB_05_2019.

29. Synthesis and Antimycobacterial Evaluation of New 5-(1-Benzyl-1H-1,2,3-triazol-4-yl)-4-methyl-2-arylthiazole Derivatives. Shinde, V., P. Mahulikar, P.C. Mhaske, S. Chakraborty, A. Choudhari, S. Phalle, P. Choudhari, and D. Sarkar. Medicinal Chemistry Research, 2019. 28(6): p. 805-819. ISI[000467266700001].
[WOS]. TB_05_2019.

30. Secondary Metabolites from Triclisia gilletii (De Wild) Staner (Menispermaceae) with Antimycobacterial Activity against Mycobacterium tuberculosis. Tiam, E.R., D.S. Ngono Bikobo, A.Z.A. Abouem, N. Mbabi Nyemeck, 2nd, E.D.F. Moni Ndedi, P.H. Betote Diboue, M.A. Nyegue, A.T. Atchade, D. Emmanuel Pegnyemb, C.G. Bochet, and U. Koert. Natural Product Research, 2019. 33(5): p. 642-650. PMID[29144174].
[PubMed]. TB_05_2019.

31. Benzothiazole Analogs as Potential anti-TB Agents: Computational Input and Molecular Dynamics. Venugopala, K.N., M.A. Khedr, M. Pillay, S.K. Nayak, S. Chandrashekharappa, B.E. Aldhubiab, S. Harsha, M. Attimard, and B. Odhav. Journal of Biomolecular Structure and Dynamics, 2019. 37(7): p. 1830-1842. PMID[29697293].
[PubMed]. TB_05_2019.

32. In Vitro and in Vivo Activities of the Riminophenazine TBI-166 against Mycobacterium tuberculosis. Xu, J., B. Wang, L. Fu, H. Zhu, S. Guo, H. Huang, D. Yin, Y. Zhang, and Y. Lu. Antimicrobial Agents and Chemotherapy, 2019. 63(5): e02155-02118. PMID[30782992].
[PubMed]. TB_05_2019.

33. Thermal, Spectral and Biological Characterisation of Copper(II) Complexes with Isoniazid-based Hydrazones. Zarafu, I., M. Badea, G. Ionita, M.C. Chifiriuc, C. Bleotu, M. Popa, P. Ionita, A. Tatibouet, and R. Olar. Journal of Thermal Analysis and Calorimetry, 2019. 136(5): p. 1977-1987. ISI[000466162800010].
[WOS]. TB_05_2019.

34. Novel Amphiphilic Cyclobutene and Cyclobutane cis-C18 Fatty acid Derivatives Inhibit Mycobacterium avium Subsp. paratuberculosis Growth. Zinniel, D.K., W. Sittiwong, D.D. Marshall, G. Rathnaiah, I.T. Sakallioglu, R. Powers, P.H. Dussault, and R.G. Barletta. Veterinary Sciences, 2019. 6(2): E46. PMID[31137605].
[PubMed]. TB_05_2019.

Patent Citations

This month, no relevant Mycobacterium patents were identified.